6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor. 1988

D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
Farmitalia C. Erba, R.&D./Oncology, Nerviano (MI), Italy.

FCE 24304 (6-methylenandrosta-1,4-diene-3,17-dione), a new irreversible aromatase inhibitor, has been identified and characterized in vitro and in vivo. The compound caused time-dependent inactivation of human placental aromatase with a t1/2 of 13.9 min and ki of 26 nM. When tested in PMSG-treated rats, ovarian aromatase activity was reduced 24 h after dosing by both the s.c. (ED50 1.8 mg/kg) and the oral (ED50 3.7 mg/kg) routes. No interference with 5 alpha-reductase activity nor any significant binding affinity for estrogen receptor was found. Slight binding affinity for the androgen receptor (RBA 0.2% of DHT) was observed.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008861 Microsomes Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) Microsome
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011467 Prostate A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM. Prostates
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D005260 Female Females

Related Publications

D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
January 1989, Cancer chemotherapy and pharmacology,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
February 1992, Journal of chromatography,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
November 1993, Steroids,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
September 1996, The Journal of steroid biochemistry and molecular biology,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
September 2009, The Journal of steroid biochemistry and molecular biology,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
November 1992, Cancer research,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
January 1989, Cancer chemotherapy and pharmacology,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
January 1989, Journal of steroid biochemistry,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
November 2014, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences,
D Giudici, and G Ornati, and G Briatico, and F Buzzetti, and P Lombardi, and E di Salle
December 2002, Die Pharmazie,
Copied contents to your clipboard!